Can a contact lens help treat glaucoma?

June 28, 2013 by Allyson Rowley, McMaster University

While an undergraduate in biochemistry at McMaster, Michelle Fernandes worked as a researcher for a biotech company. Now a master's candidate in chemical engineering, she credits that co-op work experience with sparking her interest in applied science.

"I definitely knew I wanted to work in an area that involved health care or medical devices, and I thought was really interesting," she says. For her master's thesis, Fernandes is exploring one way in which we might administer drug into the eyes of glaucoma patients, using a special kind of contact lens.

Currently, when a glaucoma patient attempts to administer his or her medicine, much of the drug is wasted and will not make it past the cornea. "Only about five per cent of the drug actually gets to the intraocular tissue," says Fernandes. By using a contact lens, the aim is to increase the contact time on the cornea, which would then increase the chance of getting the drug to where it needs to be, without the patient having to worry about it.

Fernandes' thesis is titled "Silica particles for hydrophobic drug delivery from silicone hydrogels." In a nutshell, this means: Is it possible to load silica particles (which contain the drug) into a silicone hydrogel material, in order to prolong the delivery of the drug into the eyes of patients?

Fernandes chose the topic from a list provided by her thesis supervisor, Heather Sheardown, a professor of chemical engineering at McMaster and Associate Dean of Graduate Studies (Engineering). "I'd already done some particle synthesis work in that co-op experience with the ," explains Fernandes. "The idea of exploring drug delivery, through particles loaded into contact lenses, was really interesting to me."

Fernandes points out that the concept of using contact lenses for drug delivery has been around since the 1960s. Researchers in Sheardown's lab are pushing that idea further – for example, by exploring different silicone hydrogel-based materials (some of which are now used in contact lenses that can be worn overnight). "Ideally, we'd like to get the drug delivered through silicone hydrogels, because they have the potential for prolonged wear," Fernandes says. Silicone – not to be confused with "silicon" – allows oxygen to permeate the hydrogel material and pass through the cornea.

She explains that her research is somewhat different from that of her colleagues in the lab. Rather than adding the drug directly into the gel formulation, she is experimenting with incorporating drug-loaded particles into the silicone hydrogel, which may protect the drug from the synthesis procedure and act as an additional barrier to drug release – very important, so that the drug is released in a controlled manner and over a prolonged period of time. "By loading the drug into a particle, you might be able to tune particle properties to assist in controlling the drug release behaviour," Fernandes explains.

Can we look forward to a time when we can get prescription contact lenses with our own personalized formulation loaded into them? Perhaps. In the meantime, much research still needs to be done – and that's well before any testing can begin (first on cells, then animals, and then humans). Fernandes points out that, right now, her lens materials are not as transparent as they would need to be to become viable .

"As with any research, there's a lot of reading papers and reviewing the literature. You develop your protocols and you really work on your methodology to tune your system to get it to work. Sometimes things work, and a lot of the time they don't. But when they do, it's great!"

Fernandes hopes to wrap up her thesis by the end of the summer. She credits her McMaster experience with teaching her valuable skills, such as problem solving, attention to detail, and the ability to design experiments. It has also given her the opportunity to interact with experienced scientists in a collegial lab environment. Her goal is to work in industry, conducting research on medical devices or in the pharmaceutical field.

"I really enjoy this, because it's actually affecting humans and health care, and potentially improving the quality of life. I think that's really great."

Explore further: Smart contact lenses could make eye drops a thing of the past

Related Stories

Smart contact lenses could make eye drops a thing of the past

November 9, 2011
(Medical Xpress) -- An Auburn University team of chemical and biomedical engineers led by Mark Byrne, the Daniel F. and Josephine Breeden Associate Professor in the Samuel Ginn College of Engineering, has developed a new ...

Contacts uncomfortable? Changing lens type or lens care product may help

May 1, 2013
If your contact lenses are causing you discomfort, simply switching to a different type of contact lens or lens care product may bring improvement, reports a study, " Effect of Lens and Solution Choice on the Comfort of Contact ...

Morning vs nighttime replacement affects adverse events with extended-wear contact lenses

December 10, 2012
For people using 30-day extended-wear/continuous-wear (EW/CW) contact lenses, replacing lenses at night doesn't lower the risk of complications compared to changing lenses monthly, suggests a study – "The Effect of Daily ...

Recommended for you

Study advances gene therapy for glaucoma

January 16, 2018
While testing genes to treat glaucoma by reducing pressure inside the eye, University of Wisconsin-Madison scientists stumbled onto a problem: They had trouble getting efficient gene delivery to the cells that act like drains ...

New study offers added hope for patients awaiting corneal transplants

January 9, 2018
New national research led by Jonathan Lass of Case Western Reserve University School of Medicine has found that corneal donor tissue can be safely stored for 11 days before transplantation surgery to correct eye problems ...

Diabetic blindness caused and reversed "trapped" immune cells in rodent retinas

January 3, 2018
Johns Hopkins researchers have discovered a cell signaling pathway in mice that triggers vision loss in patients with diabetic retinopathy and retinal vein occlusion – diseases characterized by the closure of blood vessels ...

Ophthalmologists increasingly dissatisfied with electronic health records

December 29, 2017
Ophthalmologists' use of electronic health records (EHR) systems for storing and accessing patients' medical histories more than doubled between 2006 and 2016, while their perceptions of financial and clinical productivity ...

Higher omega-3 fatty acid intake tied to lower glaucoma risk

December 26, 2017
(HealthDay)—Increased daily intake of ω-3 fatty acids is associated with lower odds of glaucoma, but higher levels of total polyunsaturated fatty acid (PUFA) intake are associated with higher odds of developing glaucoma, ...

Protein analysis allows for treatment of eye-disease symptoms with existing drugs

December 21, 2017
Demonstrating the potential of precision health, a team led by a researcher at the Stanford University School of Medicine has matched existing drugs to errant proteins expressed by patients with a rare eye disease.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PPihkala
not rated yet Jul 09, 2013
Even when lenses are not transparent they could be worn at night to deliver the drugs during sleep.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.